My treatment for aggressive lymphoma has been successful but severely weakened my immune system. Like many others, antimicrobial resistance could kill me, even if the cancer itself is survivable
My entire professional career, spanning nearly four decades, has been in cancer care. On 12 August 2022, at the age of 64, I was myself diagnosed with mantle cell lymphoma, a rare and aggressive type of cancer that affects the immune system and has a very poor prognosis – I was told that survival without treatment would be only eight weeks.
I was fortunate to have access to Australia’s world-class care. I received chemotherapy and a stem cell transplant, and by World Cancer Day in February 2024, I was in remission.
About Author
More Stories
Bizarre Australian mole even more unusual than first thought, new research reveals
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict